SEOUL, Aug. 23 (Korea Bizwire) — Samsung Medical Center, one of South Korea’s top general hospitals, said Monday it had introduced a home training program based on augmented reality (AR) technology for the rehabilitation of stroke patients. The program uses a sensor attached to an AR monitor installed in patients’ homes. The sensor automatically checks [...]
SEOUL, Aug. 22 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc. has opened a research and development (R&D) office in Boston to help accelerate its new drug development capabilities in the United States, according to company officials Monday. Celltrion completed the establishment of the Boston R&D office earlier this year and hired local office [...]
SEOUL, Aug. 22 (Korea Bizwire) — South Korean beauty care behemoth Amorepacific Group said it has developed a chipless wireless electronic skin that enables accurate analysis and measurement of skin conditions anytime and anywhere without heavy equipment. In general, clinical skin research requires the use of high-priced diagnosis equipment as well as maintaining a stable [...]
SEOUL, Aug. 19 (Korea Bizwire) — Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday it has secured a 110 billion-won (US$83 million) drug substance supply deal from Teva Pharmaceutical Industries Ltd. for use in producing the Israel-based generic drugmaker’s migraine medicine. Under the contract manufacturing organization (CMO) deal, Celltrion will provide drug substance [...]
SEOUL, Aug. 18 (Korea Bizwire) — SD Biosensor Inc., a South Korean developer of COVID-19 test kits, said Thursday it has signed a deal worth 148.3 billion won (US$112.3 million) to supply COVID-19 test kits to Japan. SD Biosensor said it will provide two types of test products — a type that can diagnose both [...]
SEOUL, Aug. 12 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Friday it has tentatively agreed to work with multinational pharmaceutical company AstraZeneca on biopharmaceutical contract manufacturing. The company said in a regulatory filing that it signed a letter of intent on the cooperation in a deal valued [...]
SEOUL, July 20 (Korea Bizwire) — South Korea’s state-run National Institute of Infectious Diseases (NIID) said Wednesday it has reached an agreement with Moderna Inc., a U.S. biotech company, to cooperate in the development of a messenger RNA (mRNA) vaccine candidate for severe fever and thrombocytopenia syndrome (SFTS). The institute said the deal, signed Monday, [...]
SEOUL, July 20 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Bioepis Co. was in the process of acquiring regulatory approval from European and South Korean drug authorities for SB12, a paroxysmal nocturnal hemoglobinuria (PNH) treatment biosimilar candidate, industry sources said Wednesday. The company has submitted approval applications for SB12, a more affordable version of [...]
SEOUL, July 14 (Korea Bizwire) — SK Biopharmaceuticals Co., a biopharmaceutical affiliate of South Korea’s SK Group, said Thursday it has signed a deal with Eurofarma Laboratorios SA to develop and commercialize its anti-epileptic drug Cenobamate in 17 Latin American countries. Under the deal, SK Biopharmaceuticals will receive an upfront payment of US$62 million and [...]
SEOUL, July 11 (Korea Bizwire) — Johnson & Johnson (J&J) MedTech Korea, the South Korean unit of U.S. pharmaceutical giant J&J SA’s medical devices affiliate, plans to hold discussions on deregulation in the area of bio research with the new Seoul administration under President Yoon Suk-yeol, its country general manager said Monday. The announcement by [...]